reports
- Mihail Dimitrov
- Veselin Radoychev Please Change Surname
Morning Bulletin - 31 March 2025
Positive sentiment on Friday raised SOFIX by 0.80% to 910.69, a level we haven’t seen since 2008. Eurohold (EUBG, BGN 1.94, +2.11%), First Investment Bank (FIB, BGN 4.08, +2.00%) and Shelly Group (SLYG, EUR 37.90, +1.61%) led the daily gainers with moderate daily volume. Negative impact on the main index came from Sirma Group Holding (SGH, BGN 1.10, -0.90%) and Wiser (WISR, BGN 4.90, -0.81%). BGBX40 (173.89, +0.56%) also registered green session on the back of Industrial Capital Holding (HIKA, B...
- Mihail Dimitrov
- Veselin Radoychev Please Change Surname
Morning Bulletin - 21 March 2025
Huge opposite moves of index members fixed SOFIX almost unchanged at 901.53 (-0.07%) on Thursday. Agria Group Holding (AGH, BGN 21.10, -4.09%), Bulgarian Stock Exchange (BSE, BGN 7.75, -0.64%) and Central Cooperative Bank (CCB, BGN 1.61, -0.62%) slipped without significant daily volume while Elana Agrocredit (EAC, BGN 1.06, -0.93%) suffered from big selling pressure and closed negative. Sirma Group Holding (SGH, BGN 1.10, +2.80%) and Chimimport (CHIM, BGN 0.745, +1.36%) and Bulgarian Real Estate...
Achieve Life Sciences Reports Financial Results for Fourth Quarter and...
Achieve Life Sciences Reports Financial Results for Fourth Quarter and Year-End 2024 and Provides Update on the Cytisinicline Development Program Reiterates Planned Cytisinicline NDA Submission Expected at the End of Q2 2025 Company to Host Conference Call at 8:30 AM EDT Today, Tuesday, March 11, 2025 SEATTLE and VANCOUVER, British Columbia, March 11, 2025 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage specialty pharmaceutical company focused on the global development and commercialization of cytisinicline as a treatment of nicotine dependen...
Achieve Life Sciences to Present at the Barclays 27th Annual Global He...
Achieve Life Sciences to Present at the Barclays 27th Annual Global Healthcare Conference SEATTLE and VANCOUVER, British Columbia, March 07, 2025 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage specialty pharmaceutical company focused on the global development and commercialization of cytisinicline as a treatment of nicotine dependence for smoking cessation, today announced that the company will be presenting at the Barclays 27th Annual Global Healthcare Conference to be held March 11-13, 2025, in Miami, FL. Rick Stewart, Chief Executive Officer of Achieve, w...
Achieve Life Sciences to Announce Fourth Quarter and Year-End 2024 Fin...
Achieve Life Sciences to Announce Fourth Quarter and Year-End 2024 Financial Results and Host Conference Call and Webcast on March 11, 2025 SEATTLE and VANCOUVER, British Columbia, March 06, 2025 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage specialty pharmaceutical company focused on the global development and commercialization of cytisinicline as a treatment of nicotine dependence for smoking cessation, today announced it will report its fourth quarter and year-end 2024 financial results and provide an update on the cytisinicline development program on Tue...
- Mihail Dimitrov
- Veselin Radoychev Please Change Surname
Morning Bulletin - 4 March 2025
The Bulgarian market had a rough showing on Friday though the initial selling pressure in the early hours was replaced by more optimistic price actions at the end on the session. The major indexes settled mixed as Agria Group (AGH, BGN 20.40, -2.86%) and the heavy member Shelly Group (SLYG, EUR 37.50, -0.53%) weighed on the indexes, while M+S Hydraulic (MSH, BGN 9.35, +2.19%) and Smart Organic (SO, BGN 26.20, +2.34%) recovered the losses on the opposite side. SOFIX (904.25, -0.13%) slipped below...
- Mihail Dimitrov
- Veselin Radoychev Please Change Surname
Morning Bulletin - 21 February 2025
The opposite moves of index members fixed SOFIX (902.61, +0.05%) almost unchanged. The drops of First Investment Bank (FIB, BGN 3.80, -2.56%), Sopharma (SFA, BGN 5.80, -1.69%) and Chimimport (CHIM, BGN 0.70, -1.41%) fully offset the positive move of Bulgarian Stock Exchange (BSE, BGN 7.70, +2.67%). BGREIT (217.28, +0.21%) closed slightly positive reflecting the north move of Bulgarian Real Estate Fund (BREF, BGN 4.16, +0.97%). Small speculative trades dominated the trading session on Thursday an...
Achieve Life Sciences to Present at the Oppenheimer Healthcare Life Sc...
Achieve Life Sciences to Present at the Oppenheimer Healthcare Life Sciences Conference SEATTLE and VANCOUVER, British Columbia, Feb. 11, 2025 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage specialty pharmaceutical company focused on the global development and commercialization of cytisinicline for smoking cessation and nicotine dependence, today announced that Rick Stewart, Chief Executive Officer of Achieve, will be presenting today at the virtual Oppenheimer 35th Annual Healthcare Life Sciences Conference on Tuesday, February 11, 2025, at 10:00 a.m. EST. ...
- Mihail Dimitrov
- Veselin Radoychev Please Change Surname
Morning Bulletin - 11 February 2025
The Bulgarian market settled the first day of the week mixed as the negative bias came from light-volume trades with recent top gainers, like M+S Hydraulic (MSH, BGN 8.80, -6.88%), Synergon (SNRG, 0.985, -4.37%) and Korado (KBG, BGN 4.14, -5.91%). The advancer-decliner line was in balance within SOFIX (896.11, +0.20%) and settled slightly above previous close led by Sopharma (SFA, BGN 5.78, +1.40%) and Bulgarian Real Estate (BREF, BGN 4.22, +1.93%). The block trades with Synthetica (SYN, BGN 72....
Achieve Life Sciences Announces Positive Outcome of Second Data Safety...
Achieve Life Sciences Announces Positive Outcome of Second Data Safety Monitoring Committee Review for the ORCA-OL Clinical Trial No Safety Concerns Identified by DSMC in the ORCA-OL Long-Term Exposure Trial Achieve Reiterates Planned Cytisinicline NDA Submission in Q2 2025 SEATTLE and VANCOUVER, British Columbia, Feb. 10, 2025 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage specialty pharmaceutical company focused on the global development and commercialization of cytisinicline for smoking cessation and nicotine dependence, today announced that the Data Saf...
- Martin Dimitrov
- Veselin Radoychev Please Change Surname
Weekly bulletin - 27 January - 31 January 2025
The Bulgarian stock market managed to end the week slightly higher on Friday, while global markets continued with the volatile performance. The local Benchmark SOFIX added 0.5% to settle at 892.36, as all the other major indexes closed up, ranging from 0.1% to 0.7%. The shares of three companies- SOFIX members were the top gainers within our list of selected names – Sirma Group Holding (SGH, BGN 1.00, +6.4%), Bulgarian Real Estate Fund (BREF, BGN 4.08, +4.1%) and Central Cooperative Bank (CCB,...
- Mihail Dimitrov
- Veselin Radoychev Please Change Surname
Morning Bulletin - 31 January 2025
There was some increased activity under the surface on a broad range of sectors, though the main indexes settled near previous session’s levels. Sirma Group (SGH, BGN 0.97, +2.11%) led the gainers and together with increased value of the real estate sector, settled SOFIX (891.87, +0.33%) and BGREIT (213.56, +0.11%) with gains. The widened Bid/Ask spreads accelerated the negative effect of the light-volume trades with Smart Organic (SO, BGN 23.40, -4.88%) and Stara Planina (SPH, BGN 8.65, -3.89%)...
Weekly bulletin - 20 January - 24 January 2025
All indexes on the BSE retraced during the last week with the blue-chip SOFIX falling the least (887.56, -0.3%), while the broader BGTR30 dropped the most (854.80, -0.8%). The gainers within out watchlist were led by Doverie United Holding (DUH, BGN 8.06, +3.3%), which rose on the news of record profits of its subsidiary Moldindconbank. On the other hand, Wiser Technology (WISR, BGN 4.80, -5.9%) and Neochim (NEOH, BGN 27.20, -4.2%) dropped the most. Both the volumes (+114.2% YtD average) and the...
- Mihail Dimitrov
- Veselin Radoychev Please Change Surname
Morning Bulletin - 24 January 2025
Thursday’s session run under mixed actions, yet the calculations led to slight dip for the major index in range between -0.11% to -0.08%, while BGREIT (213.76) alone gained 0.44% supported by the real estate sector, represented by Bulgarian Real Estate Fund (BREF, BGN 3.92, +1.55%) and Advance Terrafund (ATER, BGN 3.25, +0.62%). Elana Agrocredit (EAC, BGN 1.07, -2.73%) led the losers within the SOFIX (891.80, -0.08%) while Synergon (SNRG, BGN 1.03, -6.36%) weighed on BGBX40 (171.63, -0.08%). The...
- Mihail Dimitrov
- Veselin Radoychev Please Change Surname
Morning Bulletin - 21 January 2025
A positive reaction to the latest financial data from the Moldavian Bank, the main subsidiary of Doverie (DUH, BGN 8.18, +4.87%) and increased buying interest in First Investment Bank (FIB, BGN 4.32, +1.89%) were the engine of this otherwise quiet first session of the week. The major indexes settled mixed as SOFIX (892.69) advanced by 0.27%, while BGBX40 (171.84, +0.08%) and BGTR30 (861.31, -0.05%) remained almost unchanged as the negative bias from Texim Bank (TXIM, BGN 3.60, -2.70%) and Sophar...
- Mihail Dimitrov
- Veselin Radoychev Please Change Surname
Morning Bulletin - 16 January 2025
The Bulgarian market had a volatile session on Wednesday, but finally the major indexes settled with small deviations from the previous close. The advancers and decliners were in balance within the SOFIX (891.23, -0.08%) as the Central Cooperative Bank (CCB, BGN 1.68, -2.33%) weighed the most on the benchmark. M+S Hydraulic (MSH, BGN 9.30, -2.11%), Neochim (NEOH, BGN 27.20, -2.16%) and Zarneni Hrani (ZHBG, BGN 0.13, -2.26%) added a negative spice to broad indexes. Despite the light-volume choppy...
- Mihail Dimitrov
- Veselin Radoychev Please Change Surname
Bulgaria Outlook 2025
OUTLOOK 2025 – 6 VALUE STOCKS FOR YOUR PORTFOLIO Bulgaria's economy showed resilience despite the world and domestic challenges. In the first three quarters of 2024, the country posted steady annual GDP growth of 1.9% in Q1, 2.3% in Q2 and 2.6% in Q3 (non-seasonally adjusted data). The main drivers behind the growth were the individual and government consumption, which accelerated their contribution throughout the three quarters. Inflation has been on a downward trend, aligning with global ...
Achieve Life Sciences Appoints Dr. Kristen Slaoui and Nancy Phelan to ...
Achieve Life Sciences Appoints Dr. Kristen Slaoui and Nancy Phelan to its Board of Directors New Directors Bring Extensive Leadership Experience in Corporate Strategy and Commercialization SEATTLE and VANCOUVER, British Columbia, Jan. 10, 2025 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage pharmaceutical company focused on the global development and commercialization of cytisinicline for smoking cessation and nicotine dependence, today announced that Kristen Slaoui, Ph.D., and Nancy Phelan will join its Board of Directors. Achieve also announced that curren...
- Mihail Dimitrov
- Veselin Radoychev Please Change Surname
Morning Bulletin - 8 January 2025
The Bulgarian market weakened and only few outstanding names like Shelly Group (SLYG, EUR 34.00, -2.58%), the freshly renamed Wiser Technology (WISR, BGN 5.00, -4.76%) and Doverie (DUH, BGN 7.70, -1.28%) concentrated the investors’ focus and provided significant liquidity to the market. The negative bias was reinforced by low-volume price actions with Agria (AGH, BGN 19.50, -3.47%) and First Investment Bank (FIB, BGN 4.20, -2.33%) on poor buy order side within the benchmark, while BG Agro (BGAG,...
Achieve Life Sciences Announces Critical Milestone Successfully Reache...
Achieve Life Sciences Announces Critical Milestone Successfully Reached in ORCA-OL Cytisinicline Clinical Trial Required for NDA Submission Over 300 Participants Have Completed Cumulative Six Months of Cytisinicline Treatment in the ORCA-OL Trial, Completing the Long-Term Exposure Requirement for NDA Submission ORCA-OL Long-Term Exposure Timelines Remain on Track with No Safety Concerns Identified Planned Cytisinicline NDA Submission on Target for Q2 2025 SEATTLE and VANCOUVER, British Columbia, Jan. 07, 2025 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a lat...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.